Skeletal Dysplasia Account Manager - San Diego, CA
BridgeBio
August 21, 2026
Remote friendly (United States)
United States
Sales
What You Will Do:
- Drive the launch of Infigratinib (first-in-class therapy for achondroplasia) with deep clinical acumen, urgency, and partnership with providers and families.
Location:
- West Region (multiple territories): San Diego, Los Angeles, San Jose, Seattle, Omaha, Denver, San Francisco.
Responsibilities:
- Develop and execute a territory business plan targeting geneticists, pediatric endocrinologists, orthopedic specialists, pediatricians, and multi-disciplinary skeletal dysplasia clinic teams to meet/exceed sales goals.
- Demonstrate expertise in Infigratinib, achondroplasia, and skeletal dysplasia; engage HCPs in clinically relevant, compliant discussions.
- Use sales/target data to identify growth opportunities and proactively address territory challenges; adjust priorities and develop solutions as needed.
- Partner compliantly with Field Medical Directors, Field Reimbursement Managers, Family Account Managers, and the HUB to maximize customer and family satisfaction.
- Build/maintain KOL relationships with Marketing and Medical Affairs to expand advocacy for Infigratinib.
- Operate with a “One Bridge” mindset; collaborate across the organization with integrity.
- Ensure all activities comply with applicable regulations, company policies, and Pharma guidelines.
Who You Are (Qualifications/Skills):
- 8–10 years in pharma/biotech; 4+ years in rare disease/genetic disease/skeletal dysplasia (achondroplasia or pediatric rare disease preferred).
- BS/BA required; MBA a plus.
- Extensive travel.
- Product/indication launch experience; account management success analyzing complex accounts and driving strategy/implementation.
- Strong leadership, communication, accountability, judgment, and organizational skills.
- AI fluency (curiosity/adaptability with AI-powered tools/technologies).
- Integrity and commitment to ethical/compliance culture.
- Drive the launch of Infigratinib (first-in-class therapy for achondroplasia) with deep clinical acumen, urgency, and partnership with providers and families.
Location:
- West Region (multiple territories): San Diego, Los Angeles, San Jose, Seattle, Omaha, Denver, San Francisco.
Responsibilities:
- Develop and execute a territory business plan targeting geneticists, pediatric endocrinologists, orthopedic specialists, pediatricians, and multi-disciplinary skeletal dysplasia clinic teams to meet/exceed sales goals.
- Demonstrate expertise in Infigratinib, achondroplasia, and skeletal dysplasia; engage HCPs in clinically relevant, compliant discussions.
- Use sales/target data to identify growth opportunities and proactively address territory challenges; adjust priorities and develop solutions as needed.
- Partner compliantly with Field Medical Directors, Field Reimbursement Managers, Family Account Managers, and the HUB to maximize customer and family satisfaction.
- Build/maintain KOL relationships with Marketing and Medical Affairs to expand advocacy for Infigratinib.
- Operate with a “One Bridge” mindset; collaborate across the organization with integrity.
- Ensure all activities comply with applicable regulations, company policies, and Pharma guidelines.
Who You Are (Qualifications/Skills):
- 8–10 years in pharma/biotech; 4+ years in rare disease/genetic disease/skeletal dysplasia (achondroplasia or pediatric rare disease preferred).
- BS/BA required; MBA a plus.
- Extensive travel.
- Product/indication launch experience; account management success analyzing complex accounts and driving strategy/implementation.
- Strong leadership, communication, accountability, judgment, and organizational skills.
- AI fluency (curiosity/adaptability with AI-powered tools/technologies).
- Integrity and commitment to ethical/compliance culture.